Core Viewpoint - The company, Jimin Health Management Co., Ltd., is facing a serious issue involving the alleged forgery of company seals by its vice president, He Qinghong, and her team, which has led to legal actions and potential financial liabilities [1][2]. Group 1: Incident Overview - Jimin Health reported that its vice president, He Qinghong, and her team forged company seals and used them to sign unauthorized agreements with distributors [1][2]. - The company received lawyer letters from distributors claiming they had signed supplementary agreements requiring the company to fulfill return and refund obligations [2]. - The company has initiated an investigation and reported the incident to the local police, receiving a case notification [1][2]. Group 2: Financial Impact - In 2023 and 2024, He Qinghong's team achieved sales of approximately 117.199 million yuan, but the company is currently unaware of the distributors' inventory levels, posing a risk of lawsuits for refunds [3]. - The company has reported a significant decline in sales volume for safety syringes, down 61.32% year-on-year, while sales of pre-filled catheter flushing devices increased by 807.08% [5]. - Jimin Health is expected to report a net loss of 10 to 15 million yuan for 2024, which would be an improvement compared to the previous year [6][7]. Group 3: Company Response and Future Actions - The company is cooperating with law enforcement and has taken steps to terminate He Qinghong's position and restructure her sales team [4]. - Jimin Health plans to conduct a thorough review of the business operations related to the incident and engage with external legal teams to prepare for potential litigation [4]. - The company emphasizes that its production and operations remain normal and that it will comply with legal disclosure requirements as the case progresses [4].